NDUFA11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.843200E-01
Normal-vs-Stage2
6.050600E-01
Normal-vs-Stage3
6.486000E-01
Normal-vs-Stage4
5.300600E-01
Stage1-vs-Stage2
5.732200E-01
Stage1-vs-Stage3
8.448600E-01
Stage1-vs-Stage4
1.785450E-01
Stage2-vs-Stage3
8.590000E-01
Stage2-vs-Stage4
3.025400E-01
Stage3-vs-Stage4
4.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.150800E-01
Normal-vs-AfricanAmerican
8.263200E-01
Normal-vs-Asian
3.036200E-01
Caucasian-vs-AfricanAmerican
4.615400E-01
Caucasian-vs-Asian
1.523800E-01
AfricanAmerican-vs-Asian
7.995700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.782000E-01
Normal-vs-Female
4.228400E-01
Male-vs-Female
8.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.050200E-01
Normal-vs-Age(41-60Yrs)
5.009800E-01
Normal-vs-Age(61-80Yrs)
5.729800E-01
Normal-vs-Age(81-100Yrs)
1.423750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.469000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.201200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.929600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.376800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.421200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.477800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.548400E-01
Normal-vs-Daily Drinker
3.175000E-01
Normal-vs-Weekly Drinker
3.606200E-01
Normal-vs-Occasional Drinker
5.280400E-01
Normal-vs-Social Drinker
7.100400E-01
Non Drinker-vs-Daily Drinker
8.132100E-02
Non Drinker-vs-Weekly Drinker
1.266210E-01
Non Drinker-vs-Occasional Drinker
4.772000E-01
Non Drinker-vs-Social Drinker
9.543800E-01
Daily Drinker-vs-Weekly Drinker
5.638200E-01
Daily Drinker-vs-Occasional Drinker
3.449800E-01
Daily Drinker-vs-Social Drinker
1.401190E-01
Weekly Drinker-vs-Occasional Drinker
2.563200E-01
Weekly Drinker-vs-Social Drinker
1.350570E-01
Occasional Drinker-vs-Social Drinker
5.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.567000E-01
Normal-vs-Grade 2
9.440200E-01
Normal-vs-Grade 3
8.854600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.123200E-01
Grade 1-vs-Grade 3
9.017600E-02
Grade 1-vs-Grade 4
8.567000E-01
Grade 2-vs-Grade 3
2.629000E-01
Grade 2-vs-Grade 4
9.440200E-01
Grade 3-vs-Grade 4
8.854600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.265000E-01
Normal-vs-NonDiabetic
3.868400E-01
Diabetic-vs-NonDiabetic
1.607030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.495350E-01
Normal-vs-NoPancreatitis
4.894200E-01
Pancreatitis-vs-NoPancreatitis
6.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.441200E-01
Normal-vs-N1
6.276800E-01
N0-vs-N1
1.037010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.752600E-01
Normal-vs-TP53-NonMutant
8.486600E-01
TP53-Mutant-vs-TP53-NonMutant
9.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
